EE03514B1 - Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon - Google Patents

Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon

Info

Publication number
EE03514B1
EE03514B1 EE9700165A EE9700165A EE03514B1 EE 03514 B1 EE03514 B1 EE 03514B1 EE 9700165 A EE9700165 A EE 9700165A EE 9700165 A EE9700165 A EE 9700165A EE 03514 B1 EE03514 B1 EE 03514B1
Authority
EE
Estonia
Prior art keywords
aids
compounds
treatment
combination
pharmaceutical composition
Prior art date
Application number
EE9700165A
Other languages
English (en)
Other versions
EE9700165A (et
Inventor
A. Chodakewitz Jeffrey
A. Emini Emilio
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9700165A publication Critical patent/EE9700165A/et
Publication of EE03514B1 publication Critical patent/EE03514B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EE9700165A 1995-02-01 1996-01-29 Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon EE03514B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection
PCT/US1996/001417 WO1996023509A1 (en) 1995-02-01 1996-01-29 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc

Publications (2)

Publication Number Publication Date
EE9700165A EE9700165A (et) 1998-02-16
EE03514B1 true EE03514B1 (et) 2001-10-15

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700165A EE03514B1 (et) 1995-02-01 1996-01-29 Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon

Country Status (38)

Country Link
US (1) US6689761B1 (et)
EP (1) EP0806957B1 (et)
JP (1) JPH10513186A (et)
KR (1) KR19980701856A (et)
CN (1) CN1160081C (et)
AR (1) AR002957A1 (et)
AT (1) ATE243519T1 (et)
AU (1) AU711176B2 (et)
BR (1) BR9607714A (et)
CA (1) CA2211973A1 (et)
CO (1) CO4700430A1 (et)
CZ (1) CZ244497A3 (et)
DE (1) DE69628819T2 (et)
DK (1) DK0806957T3 (et)
DZ (1) DZ1988A1 (et)
EA (1) EA000437B1 (et)
EE (1) EE03514B1 (et)
ES (1) ES2200052T3 (et)
FI (1) FI973184A (et)
HK (1) HK1004659A1 (et)
HR (1) HRP960045B1 (et)
HU (1) HUP9800810A3 (et)
IL (1) IL116925A (et)
IS (1) IS1970B (et)
MX (1) MX9705916A (et)
MY (1) MY121604A (et)
NO (1) NO314568B1 (et)
NZ (1) NZ302153A (et)
PE (1) PE38397A1 (et)
PL (1) PL182742B1 (et)
PT (1) PT806957E (et)
SA (1) SA96160669B1 (et)
SK (1) SK103797A3 (et)
TR (1) TR199700735T1 (et)
TW (1) TW442291B (et)
WO (1) WO1996023509A1 (et)
YU (1) YU49417B (et)
ZA (1) ZA96722B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4088697A (en) * 1996-08-26 1998-03-19 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
WO1999047146A1 (en) * 1998-03-17 1999-09-23 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
CA2634992C (en) 2001-07-05 2012-10-16 Novartis Vaccines And Diagnostics, Inc. Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2583195A1 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
AU2006274455B2 (en) * 2005-07-27 2011-06-09 Emil Toma Zalcitabine (DDC) boosted lamivudine (3TC) compositions for antiretroviral therapy
EP3565554A4 (en) * 2017-01-04 2020-08-19 Oyagen, Inc. COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
JPH08508496A (ja) 1993-03-31 1996-09-10 メルク エンド カンパニー インコーポレーテッド Ａｉｄｓを治療する組み合わせ医薬中に存在させるｈｉｖプロテアーゼ阻害剤
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
DE69628819D1 (de) 2003-07-31
HK1004659A1 (en) 1998-12-04
EP0806957A1 (en) 1997-11-19
IL116925A0 (en) 1996-05-14
PL182742B1 (pl) 2002-02-28
SK103797A3 (en) 1998-02-04
EE9700165A (et) 1998-02-16
AR002957A1 (es) 1998-05-27
FI973184A (fi) 1997-09-30
IS4533A (is) 1997-07-29
ATE243519T1 (de) 2003-07-15
EA199700150A1 (ru) 1997-12-30
CZ244497A3 (cs) 1998-01-14
MX9705916A (es) 1997-10-31
EA000437B1 (ru) 1999-08-26
AU711176B2 (en) 1999-10-07
HUP9800810A2 (hu) 1998-07-28
HRP960045B1 (en) 2004-06-30
CO4700430A1 (es) 1998-12-29
IS1970B (is) 2004-12-15
FI973184A0 (fi) 1997-07-31
YU6396A (sh) 1999-06-15
SA96160669B1 (ar) 2006-07-30
AU4774896A (en) 1996-08-21
NZ302153A (en) 1998-12-23
WO1996023509A1 (en) 1996-08-08
PE38397A1 (es) 1997-10-09
IL116925A (en) 2000-07-26
DK0806957T3 (da) 2003-09-29
CA2211973A1 (en) 1996-08-08
CN1160081C (zh) 2004-08-04
EP0806957B1 (en) 2003-06-25
NO973533D0 (no) 1997-07-31
DE69628819T2 (de) 2004-05-13
ZA96722B (en) 1996-08-26
HUP9800810A3 (en) 2001-05-28
NO973533L (no) 1997-10-01
HRP960045A2 (en) 1997-10-31
PL321660A1 (en) 1997-12-22
MY121604A (en) 2006-02-28
BR9607714A (pt) 1998-01-13
NO314568B1 (no) 2003-04-14
TW442291B (en) 2001-06-23
DZ1988A1 (fr) 2002-07-20
YU49417B (sh) 2006-01-16
KR19980701856A (ko) 1998-06-25
TR199700735T1 (xx) 1998-02-21
JPH10513186A (ja) 1998-12-15
ES2200052T3 (es) 2004-03-01
PT806957E (pt) 2003-10-31
CN1179722A (zh) 1998-04-22
US6689761B1 (en) 2004-02-10

Similar Documents

Publication Publication Date Title
EE200000532A (et) Pürimidiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ningkombineeritud preparaat kasutamiseks HIV nakkusera
DE69625926T2 (de) Absorbierende zusammensetzung und saugfähiges wegwerfkleidungsstück, welches dasselbe enthält
IL143512A (en) Azabicycloalkanes, pharmaceuticals including them and their use in the manufacture of drugs for the prevention or treatment of infection by the immunodeficiency virus
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
ID27457A (id) Komposisi untuk pengobatan hiv dan infeksi virus lainnya
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
HUP9600455A3 (en) Use of quinoxalines combined with protease-inhibiting compounds for producing pharmaceutical compositions for treating aids and/or hiv infections
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI935654A (fi) Kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
IT1289238B1 (it) Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina
DE68906245T2 (de) Therapeutisches Mittel gegen Aids.
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
AU3530395A (en) Treatment of viral infections
AU4145999A (en) Topical drug for the treatment of viral infections
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
AU1979397A (en) Peptidomimetics for the treatment of hiv infection
KR970000449U (ko) 일회용 주사기
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
AU4500299A (en) Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20080129